187 related articles for article (PubMed ID: 16406098)
21. Pathogenicity and immunogenicity of recombinant Tiantan Vaccinia Virus with deleted C12L and A53R genes.
Dai K; Liu Y; Liu M; Xu J; Huang W; Huang X; Liu L; Wan Y; Hao Y; Shao Y
Vaccine; 2008 Sep; 26(39):5062-71. PubMed ID: 18573290
[TBL] [Abstract][Full Text] [Related]
22. Effect of the deletion of genes encoding proteins of the extracellular virion form of vaccinia virus on vaccine immunogenicity and protective effectiveness in the mouse model.
Meseda CA; Campbell J; Kumar A; Garcia AD; Merchlinsky M; Weir JP
PLoS One; 2013; 8(6):e67984. PubMed ID: 23785523
[TBL] [Abstract][Full Text] [Related]
23. Active vaccination with vaccinia virus A33 protects mice against lethal vaccinia and ectromelia viruses but not against cowpoxvirus; elucidation of the specific adaptive immune response.
Paran N; Lustig S; Zvi A; Erez N; Israely T; Melamed S; Politi B; Ben-Nathan D; Schneider P; Lachmi B; Israeli O; Stein D; Levin R; Olshevsky U
Virol J; 2013 Jul; 10():229. PubMed ID: 23842430
[TBL] [Abstract][Full Text] [Related]
24. [Construction and the immunogenicity of the recombinant Modified Vaccinia Virus Ankala co-expressing ORF4, ORF5 and ORF6 genes of porcine reproductive and Respiratory Syndrome Virus NJ-a strain].
Zheng QS; Bi ZX; Li P; Chen DS; Chen PY
Wei Sheng Wu Xue Bao; 2007 Apr; 47(2):345-9. PubMed ID: 17552247
[TBL] [Abstract][Full Text] [Related]
25. Mouse neurotoxicity test for vaccinia-based smallpox vaccines.
Li Z; Rubin SA; Taffs RE; Merchlinsky M; Ye Z; Carbone KM
Vaccine; 2004 Mar; 22(11-12):1486-93. PubMed ID: 15063573
[TBL] [Abstract][Full Text] [Related]
26. Deletion of the vaccinia virus F13L gene results in a highly attenuated virus that mounts a protective immune response against subsequent vaccinia virus challenge.
Vliegen I; Yang G; Hruby D; Jordan R; Neyts J
Antiviral Res; 2012 Jan; 93(1):160-6. PubMed ID: 22138484
[TBL] [Abstract][Full Text] [Related]
27. Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice.
Davies DH; McCausland MM; Valdez C; Huynh D; Hernandez JE; Mu Y; Hirst S; Villarreal L; Felgner PL; Crotty S
J Virol; 2005 Sep; 79(18):11724-33. PubMed ID: 16140750
[TBL] [Abstract][Full Text] [Related]
28. Vaccinia virus glycoprotein A34R is required for infectivity of extracellular enveloped virus.
McIntosh AA; Smith GL
J Virol; 1996 Jan; 70(1):272-81. PubMed ID: 8523536
[TBL] [Abstract][Full Text] [Related]
29. Identification of second-site mutations that enhance release and spread of vaccinia virus.
Katz E; Wolffe E; Moss B
J Virol; 2002 Nov; 76(22):11637-44. PubMed ID: 12388724
[TBL] [Abstract][Full Text] [Related]
30. Vaccinia virus F5 is required for normal plaque morphology in multiple cell lines but not replication in culture or virulence in mice.
Dobson BM; Procter DJ; Hollett NA; Flesch IE; Newsome TP; Tscharke DC
Virology; 2014 May; 456-457():145-56. PubMed ID: 24889234
[TBL] [Abstract][Full Text] [Related]
31. Host range, growth property, and virulence of the smallpox vaccine: vaccinia virus Tian Tan strain.
Fang Q; Yang L; Zhu W; Liu L; Wang H; Yu W; Xiao G; Tien P; Zhang L; Chen Z
Virology; 2005 May; 335(2):242-51. PubMed ID: 15840523
[TBL] [Abstract][Full Text] [Related]
32. Vaccinia virus strain LC16m8 defective in the B5R gene keeps strong protection comparable to its parental strain Lister in immunodeficient mice.
Yokote H; Shinmura Y; Kanehara T; Maruno S; Kuranaga M; Matsui H; Hashizume S
Vaccine; 2015 Nov; 33(45):6112-9. PubMed ID: 26241947
[TBL] [Abstract][Full Text] [Related]
33. B5r gene based sequence analysis of Indian buffalopox virus isolates in relation to other orthopoxviruses.
Singh RK; Balamurugan V; Hosamani M; DE UK; Chandra BM; Krishnappa M P G
Acta Virol; 2007; 51(1):47-50. PubMed ID: 17432943
[TBL] [Abstract][Full Text] [Related]
34. Effects of four antiviral substances on lethal vaccinia virus (IHD strain) respiratory infections in mice.
Smee DF; Wong MH; Bailey KW; Beadle JR; Hostetler KY; Sidwell RW
Int J Antimicrob Agents; 2004 May; 23(5):430-7. PubMed ID: 15120719
[TBL] [Abstract][Full Text] [Related]
35. Immunization with a recombinant fowlpox virus expressing a hepatitis C virus core-E1 polyprotein variant, protects mice and African green monkeys (Chlorocebus aethiops sabaeus) against challenge with a surrogate vaccinia virus.
Alvarez-Lajonchere L; Amador-Cañizares Y; Frías R; Milian Y; Musacchio A; Guerra I; Acosta-Rivero N; Martínez G; Castro J; Puentes P; Cosme K; Dueñas-Carrera S
Biotechnol Appl Biochem; 2008 Oct; 51(Pt 2):97-105. PubMed ID: 18215116
[TBL] [Abstract][Full Text] [Related]
36. Effect of the Route of Administration of the Vaccinia Virus Strain LIVP to Mice on Its Virulence and Immunogenicity.
Shchelkunov SN; Yakubitskiy SN; Sergeev AA; Kabanov AS; Bauer TV; Bulychev LE; Pyankov SA
Viruses; 2020 Jul; 12(8):. PubMed ID: 32722032
[TBL] [Abstract][Full Text] [Related]
37. Interaction between vaccinia virus extracellular virus envelope A33 and B5 glycoproteins.
Perdiguero B; Blasco R
J Virol; 2006 Sep; 80(17):8763-77. PubMed ID: 16912323
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of various virulence tests with low virulence vaccinia virus in mice.
Ludvíková V; Kutinová L; Simonová V; Otavová M
Biologicals; 1994 Jun; 22(2):187-90. PubMed ID: 7917234
[TBL] [Abstract][Full Text] [Related]
39. [Construction and characterization of non-replicating recombinant vaccinia virus expressing rabies glycoprotein].
Li P; Hu Q; Sun Z
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Jun; 13(2):170-4. PubMed ID: 12569788
[TBL] [Abstract][Full Text] [Related]
40. Measurements of vaccinia virus dissemination using whole body imaging: approaches for predicting of lethality in challenge models and testing of vaccines and antiviral treatments.
Zaitseva M; Kapnick S; Golding H
Methods Mol Biol; 2012; 890():161-76. PubMed ID: 22688767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
